Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: principles (564), values (295)

Cyclophosphamide-Docetaxel-Doxorubicin Ver 1.1

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOCETAXEL-DOXORUBICIN Regimen (TAC) Breast Cancer – Cyclophosphamide-Docetaxel-Doxorubicin (TAC) Indication Adjuvant therapy for node positive
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastCyclophosphamideDocetaxelDoxorubicinTACVer11.pdf

Keeping your baby safe - patient information

Description: We have written this factsheet to make sure your baby is cared for as safely as possible, outside and at home
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Keeping-your-baby-safe.pdf

Niraparib

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCERS Regimen NIRAPARIB • Ovarian Cancer – Niraparib Indication • Niraparib is recommended as maintenance treatment in patients with relapsed, platinum
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Niraparib.pdf

Cetuximab-Irinotecan (21day)

Description: Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB-IRINOTECAN (21 day) This regimen may require funding Regimen • Colorectal Cancer–Cetuximab-Irinotecan (21 day) Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab-Irinotecan.pdf

Cetuximab-Irinotecan (14 day)

Description: Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB-IRINOTECAN (14 day) This regimen may require funding Regimen • Colorectal Cancer–Cetuximab-Irinotecan (14 day) Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab-Irinotecan14day.pdf

Atezolizumab-Paclitaxel Albumin Bound

Description: Chemotherapy Protocol BREAST CANCER Atezolizumab-Paclitaxel Albumin Bound Regimen • Breast – Atezolizumab-Paclitaxel Albumin Bound Indication • Atezolizumab in combination with paclitaxel albumin
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Atezolizumab-Paclitaxel-Albumin-Bound.pdf

STHW869 Antibiotic Guideline Ranges 2021 - 2022

Description: Antimicrobial Reference Laboratory GUIDELINE RANGES FOR TDM 2021 - 2022 Alan Noel Antimicrobial Reference Laboratory North Bristol NHS Trust Southmead Hospital Bristol
Url: /Media/SUHTExtranet/DepartmentOfInfection/STHW869-Antibiotic-Guideline-Ranges-2021-2022.pdf

PIS COVID-19 immsup adults V2.1

Description: Participant Information Study Title: Coronavirus infection in immunosuppressed children and adults. Chief Investigator: H. de Graaf Principal investigators: H. de Graaf ,
Url: /Media/Southampton-Clinical-Research/COVID-19/ImmunoCOVID/PIS-COVID-19-immsup-adults-V2.1.pdf

ImmunoCOVID19 info for parents or carers and children aged 16-17

Description: Participant Information for parents/carers and children aged 16-17 years Study Title: Coronavirus infection in primary or secondary immunosuppressed chil
Url: /Media/Southampton-Clinical-Research/Downloads/Immunocovid/ImmunoCOVID19-info-for-parents-or-carers-and-children-aged-16-17.pdf

PIS COVID-19 immsup child - over 16 yrs and parents V1.6

Description: Participant Information for parents/carers and children aged 16-17 years Study Title: Coronavirus infection in primary or secondary immunosuppressed chil
Url: /Media/Southampton-Clinical-Research/COVID-19/PIS-COVID-19-immsup-child-over-16-yrs-and-parents-V1.6.pdf

401 to 410 of 427

Previous … 39 40 41 42 43 Next